AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference54 articles.
1. Artificial intelligence in drug discovery: a comprehensive review of data-driven and machine learning approaches;Kim;Biotechnol. Bioproc. Eng.,2020
2. Deep learning enables rapid identification of potent DDR1 kinase inhibitors;Zhavoronkov;Nat. Biotechnol.,2019
3. Discovery of pyrazolo[3,4-d]pyridazinone derivatives as selective DDR1 inhibitors via deep learning based design, synthesis, and biological evaluation;Tan;J. Med. Chem.,2021
4. Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking;Wang;PLoS Comput. Biol.,2021
5. Identification of new potent A1 adenosine receptor antagonists using a multistage virtual screening approach;Wei;Eur. J. Med. Chem.,2020
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of novel CXCR4 inhibitors for the treatment of inflammation by virtual screening and biological evaluation;European Journal of Medicinal Chemistry;2024-09
2. AI's role in pharmaceuticals: Assisting drug design from protein interactions to drug development;Artificial Intelligence Chemistry;2024-06
3. Insights into artificial intelligence utilisation in drug discovery;Journal of Medical Economics;2024-02-22
4. Anesthetic drug discovery with computer-aided drug design and machine learning;Anesthesiology and Perioperative Science;2024-01-15
5. Trustworthy Medical Operational AI: Marrying AI and Regulatory Requirements;2023 IEEE International Conference on Big Data (BigData);2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3